Clinical trial
A Randomized Multi-center Phase III Study About the Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.
NCT02942615 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Multi-center Phase III Study About the Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.
- Lead sponsor
- Ruijin Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 27, 2017
- Completion date
- October 31, 2025
- Enrollment
- 220 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.